Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe revision tag on the page changed from v3.5.3 to v3.5.4, signaling an internal update to the page's versioning. This metadata-level change does not alter the study content or visible information.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s supplementary resources section and related footer/disclaimer items were updated, and the interface/version label changed from an earlier revision to a newer one.SummaryDifference0.2%

- Check68 days agoChange DetectedRemoved the Genetic and Rare Diseases Information Center from Resources and removed the Interstitial lung disease 2 tag.SummaryDifference0.1%

- Check75 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; the update is visible in the footer and does not alter study details or page content.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check111 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2; this is a minor technical update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.